Zhengda Bio (03839) announced its interim results, with profit attributable to shareholders of $9.423 million, a decrease of 44.72% year-on-year.

19:36 11/08/2026

Zhengda Biological (03839) announced its mid-term results for 2026, with revenue of approximately 211 million USD, a decrease of 34.62% year-on-year; the profit attributable to shareholders was 9.423 million USD, a decrease of 44.72% year-on-year; earnings per share were 3.7 cents.

Zhongda Biological (03839) announced its interim results for 2026, with revenue of approximately $211 million, a year-on-year decrease of 34.62%; the profit attributable to shareholders was $9.423 million, a year-on-year decrease of 44.72%; earnings per share were 3.7 cents.

CEB BANK (06818): Yang Bingbing resigns as Vice President.

In the first seven months, CHINA JINMAO (00817) accumulated a signed sales amount of 66.702 billion yuan, an increase of 7.92% year-on-year.

CNE TECH CORP (00611) issued a profit warning, expecting a mid-term net profit of no less than 30 million yuan, a decrease of no more than 65% compared to the same period last year.

CEB BANK (06818): Yang Bingbing resigns as Vice President.

In the first seven months, CHINA JINMAO (00817) accumulated a signed sales amount of 66.702 billion yuan, an increase of 7.92% year-on-year.

CNE TECH CORP (00611) issued a profit warning, expecting a mid-term net profit of no less than 30 million yuan, a decrease of no more than 65% compared to the same period last year.